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Introduction
Breast cancer is the uncontrolled divi-
sion of  abnormal cells characterized by the 
occurrence of  malignant tumors in one of  
the organ structures. It can spread directly or 
through metastatic dissemination [1]. Breast 
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Abstract - Aim: The aim of this research was the comparison between negative emotions, body image, sexual 
schemas and   sexual function in women with breast cancer after mastectomy and healthy women. Method: 
The study included 105 married women diagnosed with breast cancer. After enrolment the participants filled 
the following questionnaires: Multidimensional Body-Self Relations Questionnaire (MBSRQ), Depression, 
Anxiety, Stress Scales (DASS-21), Questionnaire of cognitive schema activation in sexual context (QCSASC), 
Female Sexual Function Index (FSFI). After the two groups were matched in age and education, these ques-
tionnaires were administered to the control group of 100 healthy women. Descriptive statistics and t-test 
were used in data analysis. Results: Results indicate a significant difference between the total score of sexual 
dysfunction (p<0.002), body image (p<0.001), sexual schema (p<0.001) between the breast cancer group 
and healthy group. The two groups did not have a significant difference in negative emotions. Conclusion: 
The results of the current study are similar to the previous studies and can be useful for prevention of mood 
disorders and sexual dysfunction associated with breast cancer, in order to improve psychological treatment 
of women with breast cancer.
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cancer is one of  the most common cancers 
worldwide, affecting 1.67 million people ac-
cording to the 2012 GLOBOCAN series of  
the International Agency for Research on 
Cancer [2]. In Iran, breast cancer is the main 
cause of  cancer morbidity and mortality in 
women [3]. One out of  8 Iranian women be-
tween the age of  45 and 55 is likely to de-
velop breast cancer [4]. Many women expe-
rience significant stress after being informed 
of  having the disease, exacerbated by the 
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necessary treatments such as surgery and 
chemotherapy and their side effects [5]. On 
one hand, the progress of  science and the 
emergence of  new treatment options has led 
to increased life expectancy of  many patients. 
However, psychological disorders caused 
by the disease and treatment effects persist 
many years after treatment [6-10].
Sexuality is an important part of  human 
life and has an essential role in the quality 
of  life and health [11]. Sexual dysfunction in 
women with gynecologic cancer reaches 81% 
[13]. Many studies show sexual dysfunction 
in women with breast cancer [14-19].
Additionally, the results of  researches have 
considered the role of  other factors that are 
also important for the health of  women with 
breast cancer, including negative emotions, 
body image and sexual schemas [12, 19-21].
One of  the important psychological vari-
ables in patients with breast cancer are nega-
tive emotions. Negative emotions include 
anxiety, depression and stress. Negative emo-
tions are caused by unpleasant events or ex-
periences. Breast cancer treatments have 
deep psychological effects on patients due 
to changes in appearance such as hair loss, 
mastectomy or breast deformity [22, 23] and 
cause negative emotions associated with an 
unpleasant experience [24, 25]. Some re-
searches showed high prevalence of  negative 
emotions in women with breast cancer [7, 26-
33]. For example, Kissan et al studied women 
with breast cancer at the Institute of  Psychol-
ogy, University of  Melbourne, and estimated 
the prevalence of  major depression at 10%, 
mild to moderate depression at 27% and anx-
iety disorders at 9% [34].
Most researches have shown that proce-
dures that lead to loss or deformation of  a 
breast have a negative impact on body im-
age of  women with breast cancer [17, 18]. 
The body image does not reflect the actual 
appearance of  a person, it is the person’s im-
age of  the size and shape of  her body that 
includes beliefs, perception, thoughts, feel-
ings and behaviors related to physical appear-
ance [35]. Thompson (1990) points out that 
the structure of  physical appearance includes 
three components: 1) cognitive factors (es-
timation of  body size), 2) subjective factors 
(aspects such as satisfaction, attention, anxiety 
and cognitive assessment) and 3) behavioral 
components (avoiding situations that cause a 
person to consider physical appearance as a 
shameful experience). Previous studies have 
been implemented in different countries and 
races on body image in women with breast 
cancer. Many of  these researches indicated a 
body image disorder [18, 36-40]. In a study on 
an Iranian sample, the body image between 
two groups of  women with breast cancer, 
whether undergoing surgery or not, have been 
examined and no significant relationship ex-
isted between them. However these variables 
were not compared to healthy people [41].
Cognitive schemes, as the core of  a per-
son’s cognitive structure, assist the person to 
classify and interpret his or her experiences in 
meaningful ways [42]. Sexual schemes, as well 
as other schemes, guide the emotional and 
behavioral responses to external and internal 
stimuli with the meaning they give to events. 
If  that does not match the reality, it causes 
the emotional and behavioral answer that 
leads to sexual dysfunction. The researches 
on the association between sexual schemes 
and sexual function of  women with cancer in 
the United States (2007) showed that people 
with sexual dysfunction, compared to people 
with normal function, activate a negative sex-
ual scheme in sexual situations [43].
Due to the high prevalence of  breast can-
cer and the importance of  sexual function 
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and some psychological variables related to 
mental health of  patients with breast cancer 
and their families, this study aimed to com-
pare body image, negative emotions, sexual 
schemas and sexual performance between 
women with breast cancer and healthy wom-
en. In this study, sexual function was com-
pared with the control group as an impor-
tant aspect of  quality of  life and one of  the 
commonest psychological disorders in peo-
ple with this chronic disease [19]. Three other 
variables may be anticipated in the following 
researches as factors affecting the person’s 
mental state: disrupting different familial, so-
cial and occupational functions as possible 
causes of  sexual dysfunction. In the pres-
ent study the variable of  negative emotions 
in three categories of  anxiety, stress and de-
pression, and body image is studied in com-
parison with healthy subjects. The previous 
researches on Iranian samples focus only on 
patients that are not comparable to healthy 
subjects due to the lack of  a control group. 
Assessing the variable of  sexual schemes in 
people with breast cancer is a new action in 
this area. Assessing the dimensions of  this is-
sue, without significant support from Iranian 
research, can be effective for sexual dysfunc-
tion in this population and provide a platform 
for more research in this area or related areas.
Methods
Participant
The sample of  the study consisted of  
married women aged 20 to 55 with breast 
cancer who underwent surgery at least 6 
months prior to the study and follow-up can-
cer treatment in 2013-2014 in medical centers 
in Zanjan and affiliated centers of  Tehran. 
Purposive sampling was used in selecting the 
samples. The data were collected as follows: 
the researcher visited Vali-Asr and Ayatol-
lah Mousavi hospitals of  Zanjan (clinics and 
hospitals of  Zanjan University of  Medical 
Sciences), Research Center of  Jihad Univer-
sity of  Breast Cancer, Cancer Research Cen-
ter of  Shohadaye-Tajrish hospital and Azar 
Surgery Research Center (cancer-related cen-
ters in Tehran) in the first half  of  2013 and 
reviewed women aged 20 to 55 years with 
breast cancer who had undergone surgery 
at least 6 months earlier. Eligible patients re-
ferred to these treatment centers for follow-
up, willing to participate in the research and 
meeting the inclusion criteria, were intro-
duced by an oncologist or medical staff  to 
participating in the research. Finally, 120 pa-
tients were selected and included in the clini-
cal group after signing an informed consent 
form. From patients’ escorts and the hospi-
tal health care staff  115 individuals without 
breast cancer were matched by age and edu-
cation criteria as the control group. However, 
due to errors in both groups in completing 
the questionnaires, ultimately were analyzed 
105 in the breast cancer group and 100 in the 
control group.
The inclusion criteria for the clinical group 
were: age from 20 to 55 years, being married, 
history of  unilateral or bilateral breast sur-
gery, undergoing surgery at least 6 months 
prior to the implementation of  the study. 
The inclusion criteria for the control group 
were: age 20 to 55 years, being married, ab-
sence of  breast cancer. The exclusion criteria 
were: age younger than 20 or older than 55 
years, being single.
Design of the study
This study was a part of  a cross-sectional 
proposal. In this design, breast cancer was 
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considered as a prediction variable; body im-
age, negative emotions, sexual schemes, and 
sexual function was considered as a criterion 
variable.
Study measures 
Multidimensional Body-Self Relations 
Questionnaire (MBSRQ)
A 46-item self-report scale was designed 
by Cash and colleagues in 1987. The final 
form of  the questionnaire prepared in 1997 
by Cash was used in this study. This question-
naire had 6 subscales including Appearance 
Evaluation, Fitness Orientation, Body Areas 
Satisfaction, Appearance Orientation, Fitness 
Evaluation and Subjective Weight, to which 
the participants responded, based on the 
Likert scale (from strongly disagree = 1, to 
strongly agree = 5). Reliability and validity of  
this test has been validated by Cash [35]. Its 
psychometric properties have been studied 
in Iran. Cronbach’s alpha coefficients for all 
subscales are reported, 0.88, 0.85, 0.83, 0.79, 
0.91 and 0.94, respectively, which is a sign of  
a good internal consistency of  the question-
naire. Correlation coefficients for each sub-
scale within two weeks were 0.78, 0.75, 0.71, 
0.69, 0.84 and 0.89, respectively, which is a 
sign of  good test-retest reliability [44].
Female Sexual Function Index (FSFI)
This tool was designed by Rosen et al in 
2002 to assess women’s sexual function dur-
ing the past four weeks [45]. It consists of  19 
sexual function verdicts in six independent 
areas, including desire, arousal, lubrication, 
orgasm, satisfaction, and pain during sex. 
Participants responded to this based on the 
Likert scale (from never or almost never = 
1.0, to always and almost always = 5). Desire 
is scored in a subscale of  1 to 5 and the other 
factors from 0 to 5 (grade 1 and grade 5). In 
a study by Rosen and colleagues, alpha was 
0.89 and in Meston’s study 0.74 [46]. Psycho-
metric properties of  the Iranian sample were 
assessed in some studies [47, 48]. According 
to the latest study conducted by Fakhri and 
colleagues, the overall stability of  the test for 
each of  the above areas (r ranging from 0.73 
to 0.86) and acceptable internal consistency 
(α: 0.72 to 0.90).
Depression, Anxiety, Stress Scales (DASS-21)
This questionnaire was developed in 1983 
by Lovibond. The scales comprises of  21 
items with signs of  negative emotions (de-
pression, anxiety and stress). Each of  the 
three measures of  depression, anxiety and 
stress has 7 questions and the participants’ 
score in each of  the three subscales is cal-
culated by adding all expressions of  that 
subscale. Several studies have shown that 
DASS-21 subscales have good psychometric 
properties. In a non-clinical population, in-
ternal consistency coefficients of  the three 
subscales of  depression, anxiety and stress 
were 0.91, 0.84 and 0.90, respectively 0 [49] 
and in a study with clinical population were 
0.91, 0.89 and 0.93 [50]. Brown and col-
leagues also reported the test-retest reliability 
coefficients for three subscales of  DASS-21 
with an interval of  two weeks from 0.71 to 
0.81. Three-factored structure of  the scale 
is supported by DASS-21 in various studies 
[49-51]. Psychometric characteristics of  this 
questionnaire have been validated by an Ira-
nian sample. In this study, using confirmatory 
factor analysis, the three-factor structure was 
confirmed. The internal consistency coeffi-
cient scales of  depression, anxiety and stress 
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were 0.87, 0.81 and 0.87, respectively and co-
efficients of  reliability for the three subscales 
were 0.84, 0.89, and 0.90, respectively [52, 
53].
Questionnaire of cognitive schema activation 
in sexual context (QCSASC)
This questionnaire assesses 28 schemes 
associated with psychological problems. 
These schemes have been designed by JS 
Beck. The test assesses the activation of  
these schemes in 4 negative positions with 
the most likely sexual disorders. In test 
the participants are asked to read four sto-
ries. Each person must choose a story that 
is most similar to their life and specify the 
most emotional situation (anxiety, disap-
pointment, sadness, fear, guilt, shame, an-
ger, hurt, joy, and satisfaction); then the par-
ticipants were required to imagine the story 
that most fit them and rank each of  the 28 
schemes based on the Likert scale (very false 
= 1, very true = 5). The person’s score is 
the total of  the 28 items. The higher score 
indicates more activation of  the negative 
schemes. Cronbach’s alpha had a high in-
ternal consistency and the test’s coefficient 
was 0.94, and retest of  0.66 shows good re-
liability [40]. The questionnaire conducted 
on samples of  men and women addicts in 
Tehran and its reliability and validity were 
considered optimal [54].
Methods of data analysis
For data analysis, in addition to the meth-
ods of  descriptive statistics, t-test was used 
for comparison of  means and the dimen-
sions of  each variable of  negative emotions, 
body image and sexual schemes in both clini-
cal and control groups. These statistical tests 
were conducted using the computer software 
SPSS-18.
Results
The Demographic characteristics present-
ed in Table 1 included age, education level, 
years of  marriage, disease duration, unilateral 
or bilateral mastectomy in women with breast 
cancer and healthy women.
Before addressing the main results of  the 
study, it should be noted that the mean score 
obtained from testing the performance mea-
sures showed that the index of  sexual func-
tion and all its aspects was higher in healthy 
subjects than in patients and there was a sig-
nificant difference, based on the t-test, be-
tween the total score of  the two groups and 
subscales of  “lubrication”, “orgasm”, “sat-
isfaction”, and “pain”. This indicates that 
women with breast cancer have lower sexual 
function in the mentioned areas. The results 
presented in Table 2 show that the compari-
son between women with breast cancer and 
healthy women was significant in terms of  
sexual function based on the t-test.
The results presented in Table 3 showed 
that the mean score of  negative emotions 
included stress, anxiety, depression and the 
total score was higher in women with breast 
cancer. T-test showed significant difference in 
total score and scores of  depression, but the 
difference in stress and anxiety scales were 
significant at 0.05 between the two groups.
The results presented in Table 3 show that 
the mean score in all aspects of  body im-
age in women with breast cancer was lower 
than in healthy women. T-test showed a sig-
nificant difference between the two groups in 
total score of  body image, tending towards 
appearance, and satisfaction with body parts. 
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Table 1. Demographic statistics in women with breast cancer and healthy women
Demographics
Breast cancer 
(n = 105) n (%) mean
Control group 
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(N=100)  (95% CT) d p
Sexual function











































Data are presented as mean (standard deviation)
Abbreviation:  = mean difference; d =cohen’s d standardized effect size; CI=confidence interval; 
p=statiscal significance calculated using students t-test for independent samples
Table 3. Comparison of  negative emotions between the group of  women with breast cancer and 
healthy women
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Data are presented as mean (standard deviation)
Abbreviation:  = mean difference; d =cohen’s d standardized effect size; CI=confidence interval; 
p=statiscal significance calculated using students t-test for independent samples
Table 4. Comparison of  body image between the group of  women with breast cancer and healthy 
women





(N=100)  (95% CT) d p
Total score 150.56(15.44) 158.78 (12.45) -8.22 (3.20,13.41) 0.58 0.001
Appearance
Evaluation
22.02(3.81) 22.58 (4.05) 0.56 (-0.86,1.98) 0.14 0.318
Appearance  
Orientation 39.1(15.71) 42.86( 5.41) -3.74 (-0.54,8.06) 0.32 0.001
Fitness Evaluation 9.68(2.31) 10.16(1.83) -0.48 (-0.27,1.23) 0.23 0.101
Fitness Orientation 39.95(6.41) 39.03(5.49) 0.92 (-1.25,3.09) 0.15 0.281
Subjective Weight 7.18(1.56) 7.37(1.57) -0.19 (-0.37, 0.75) 0.12 0.379
Body Areas  
Satisfaction 32.92(7.51) 36.75(5.35) -3.83 (1.45, 6.20) 0.58 0.001
Data are presented as mean (standard deviation).
Abbreviation:  = mean difference; d =cohen’s d standardized effect size; CI=confidence interval; 
p=statiscal significance calculated using students t-test for independent samples
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T-test showed no significant difference in the 
evaluation of  other scales.
The results presented in Table 5 showed 
that the mean score of  negative sexual 
scheme was higher in all aspects in women 
with breast cancer than in healthy women. T-
test showed no significant difference between 
the total score of  the two groups. Thus, it 
was confirmed that women with breast can-
cer have a more negative sexual scheme than 
healthy women.
Discussion and conclusion
The aim of  this study was to compare the 
variables of  negative emotions, body image, 
sexual schemes and sexual function in wom-
en with breast cancer and healthy women. 
Before discussing the main results, it must 
be mentioned that the clinical and control 
groups were matched in terms of  age and 
education. The results showed that breast 
cancer patients had lower scores in all as-
pects of  sexual function than the healthy 
controls. This difference was significant in 
the subscales of  “lubrication”, “orgasm”, 
“satisfaction” and “pain”. Negative emo-
tions (stress, anxiety and depression) were 
higher in patients with cancer than in nor-
mal individuals, but there was no significant 
difference between the total score of  nega-
tive emotions. Scores of  women with breast 
cancer in the two subscales of  body image, 
including towards appearance and satisfac-
tion with body parts, were lower than in the 
control group and the difference was signifi-
cant. Also, women with cancer had a signifi-
cant difference in negative sexual schemes 
from the control group.
The results of  studying the negative emo-
tions in women with breast cancer are in line 
with the results of  the following research-
ers: Kissan et al [36], Morasso et al [28], Jes-
se et al [29], Khan et al [30], Alacacioglu et 
al [31], and Alavi and Monaie [7]. The high-
er mean score of  negative emotions (stress, 
anxiety and depression) in the group of  pa-
tients than the control group explained that 
women with breast cancer become closer to 
Table 5. Comparison between women with breast cancer and healthy women in subscales of  nega-
tive sexual schemas





(N=100)  (95% CT) d p
(Total score) 53.93( 20.89) 40.37 19.57 13.56 (6.2, 20.92) 0.13 0.001
Undesirability/ 
Rejection 15.44( 7.42) 12.48 8.43 2.95 (0.079,5.84) 0.02 0.009
Incompetence 16.97 (7.44) 12.28 6.14 4.68 (2.20,7.17) 0.04 0.001
Self-depreciation 4.85 (2.49) 4.11 2.10 0.74 (_0.1,1.58) 0.007 0.026
Difference and  
loneliness 7.23 (2.88) 4.67 2.62 2.56 (1.55,3.56) 0.02 0.001
Hopeless 9.41 (4.33) 6.80 4.06 2.61 (1.08,4.13) 0.02 0.001
Data are presented as mean (standard deviation)
Abbreviation:  = mean difference; d =cohen’s d standardized effect size; CI=confidence interval; 
p=statiscal significance calculated using students t-test for independent samples
57
Archives of Psychiatry Research 2019;55:49-60Sexuality in women with breast cancer 
the issues associated with psychopathology. 
Women who undergo surgery experience 
significant stress and tension due to the dis-
ruption of  their body image. Thus, they may 
use emotion-focused coping mechanisms 
[55] that may cause high levels of  anxiety 
and depression [56]. Higher scores of  neg-
ative emotions in women with cancer and, 
at the same time, no significant relationship 
between the scores of  the two groups, indi-
cate the importance of  assessing the details 
of  the negative emotions and psychologi-
cal, social and family infrastructure in both 
groups.
The results of  the body image are also 
consistent with findings of  previous research-
ers, including researches by Fobair et al [18], 
Barni [38], Bakht and Najafi [42] and Harir-
chi et al [16]. In explaining the problems re-
lated to body image and sexual function, the 
findings of  Fabiar et al [18] pointed out that 
most of  the problems in patients with breast 
cancer are associated with chemotherapy-
induced factors such as hair loss, increased 
concerns of  weight gain or weight loss, im-
paired mental health, low self-esteem and low 
understanding of  the patient’s sexual partner. 
This explanation is in line with researches by 
Boquiren et al [19], Male et al [40]. 
The results of  this study regarding the 
negative sexual scheme in the clinical group 
is consistent with the researches by Nobre 
and Pinto-Gouveia [44] on the incidence and 
types of  negative sexual schemes in the af-
fected female patients. There was a signifi-
cant difference between  healthy women and 
women with breast cancer in all subscales 
of  negative sexual schemas Undesirability/
rejection, Incompetence, Self-depreciation, 
Difference/loneliness, and Helplessness.
The relationship between sexual schemes 
and sexual function is one of  the areas that 
has been considered only recently and previ-
ously less studied. Women with cancer show 
more negative sexual schema due to the pres-
ence of  disease and secondary sexual dys-
function. Due to the illness, parts of  the sex-
ual function is impaired, such as lubrication 
and sex drive, which are affected by cancer 
treatments such as radiotherapy, chemothera-
py and prevention drugs.  Thus, it seems that 
the person does not control these physiologi-
cal changes, so she experiences loss of  con-
trol, helplessness and inadequacy. The results 
of  Nobre and Pinto-Gouveia [44] have also 
confirmed this.
One of  the limitations of  this study was 
not including the individual’s stressors and 
mental state in the family before the disease 
onset and neglecting the role of  the patient’s 
spouse and the communication patterns as 
the main factor in the patient’s sex life. Thus, 
this study was based on purposive sampling 
with a higher risk of  sampling bias. It is rec-
ommended that future studies consider the 
role of  the patient’s spouse and the role of  
psychosocial stressors on sexual function. 
The results of  this study provide useful 
information to clinical psychologists, physi-
cians and researchers in the context of  nega-
tive emotions, body image, sexual schemes 
and sexual function in breast cancer patients 
that can be used and cited in different areas 
of  research, prevention and treatment. It is 
an effective step towards improving the qual-
ity of  psychological treatment and preven-
tion of  mood disorders and sexual function 
in breast cancer patients and improving their 
quality of  life.
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Usporedba negativnih emocija, slike o tijelu, spolnih shema i 
seksualne funkcije u žena s rakom dojke i zdravih žena
Sažetak - Cilj istraživanja je usporedba negativnih emocija, slike o tijelu, spolnih shema i seksualne funkcije 
žena s rakom dojke nakon mastektomije i zdravih žena. Za istraživanje je odabrano 105 udanih žena s rakom 
dojke. Nakon odabira kandidatkinje su ispunile sljedeće upitnike: multidimenzionalni upitnik o korelatima 
zadovoljstva tijelom (MBSRQ), skale za depresiju, anksioznost, stres (DASS-21), upitnik o aktivaciji kognitivnih 
shema u seksualnom kontekstu (QCSASC) i indeks ženske seksualne funkcije (FSFI). U skladu s dobi i obrazo-
vanjem ispitanica, upitnici su podijeljeni kontrolnoj skupini od 100 zdravih žena; podaci su analizirani pomoću 
deskriptivne statistike i t-testa. Rezultati ukazuju na značajnu razliku u ukupnom rezultatu seksualne disfunk-
cije (p<0/002), slike o tjelu (p<0/001), spolnoj shemi (p<0/001) između zdrave skupine i skupine s rakom. 
Između skupina nije otkrivena značajna razlika u negativnim osjećajima. Rezultat ovog istraživanja sličan je 
onima iz prethodnih istraživanja te može biti koristan u daljnjem istraživanju prevencije i liječenja raka dojke 
u svrhu poboljšanja kvalitete psihološke pomoći u liječenju žena s rakom dojke.
Ključne riječi: rak dojke, negativne emocije, slika o tijelu, spolne sheme, seksualna funkcija.
